These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 1555061)
1. Accurate method to measure the percentage hepatic replacement by tumour and its use in prognosis of patients with advanced colorectal cancer. Purkiss SF; Williams NS Br J Surg; 1992 Feb; 79(2):136-8. PubMed ID: 1555061 [TBL] [Abstract][Full Text] [Related]
2. Automated measurement of tumour extent in patients with colorectal liver metastases from X-ray computed tomography. Perring S; Hunt TM; Fleming JS; Blaquiere RM; Taylor I Br J Radiol; 1991 Jun; 64(762):494-7. PubMed ID: 2070177 [TBL] [Abstract][Full Text] [Related]
3. Growth rate and percentage hepatic replacement of colorectal liver metastases. Purkiss SF; Williams NS Br J Surg; 1993 Aug; 80(8):1036-8. PubMed ID: 8402061 [TBL] [Abstract][Full Text] [Related]
4. The assessment of percentage hepatic replacement using planimetry of computerized tomographic images. Purkiss SF Surg Oncol; 1996; 5(5-6):231-6. PubMed ID: 9129135 [TBL] [Abstract][Full Text] [Related]
6. Determinants of survival in patients with unresectable colorectal liver metastases. Chang AE; Steinberg SM; Culnane M; White DE J Surg Oncol; 1989 Apr; 40(4):245-51. PubMed ID: 2927137 [TBL] [Abstract][Full Text] [Related]
7. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases? Bakalakos EA; Burak WE; Young DC; Martin EW Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299 [TBL] [Abstract][Full Text] [Related]
9. Survival after repeat hepatic resection for recurrent colorectal metastases. Chiappa A; Zbar AP; Biella F; Staudacher C Hepatogastroenterology; 1999; 46(26):1065-70. PubMed ID: 10370668 [TBL] [Abstract][Full Text] [Related]
10. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases. Wiering B; Krabbe PF; Jager GJ; Oyen WJ; Ruers TJ Cancer; 2005 Dec; 104(12):2658-70. PubMed ID: 16315241 [TBL] [Abstract][Full Text] [Related]
11. Resection of Concomitant Hepatic and Extrahepatic Metastases from Colorectal Cancer - A Worthwhile Operation? Diaconescu A; Alexandrescu S; Ionel Z; Zlate C; Grigorie R; Brasoveanu V; Hrehoret D; Ciurea S; Botea F; Tomescu D; Droc G; Croitoru A; Herlea V; Boros M; Grasu M; Dumitru R; Toma M; Ionescu M; Vasilescu C; Popescu I Chirurgia (Bucur); 2017; 112(6):673-682. PubMed ID: 29288609 [TBL] [Abstract][Full Text] [Related]
12. [Liver metastasis. Clinico-pathological prognostic factors in metastasis from colorectal cancer]. Doci R; Bignami P; Gennari L Ann Ital Chir; 1996; 67(6):761-5. PubMed ID: 9214268 [TBL] [Abstract][Full Text] [Related]
13. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases. Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156 [TBL] [Abstract][Full Text] [Related]
14. Analysis of prognostic factors after resection of solitary liver metastasis in colorectal cancer: a 22-year bicentre study. Acciuffi S; Meyer F; Bauschke A; Settmacher U; Lippert H; Croner R; Altendorf-Hofmann A J Cancer Res Clin Oncol; 2018 Mar; 144(3):593-599. PubMed ID: 29340767 [TBL] [Abstract][Full Text] [Related]
15. Prediction of survival in patients with unresectable colorectal liver metastases. Hołówko W; Grąt M; Hinderer B; Orlińska I; Krawczyk M Pol Przegl Chir; 2014 Jul; 86(7):319-24. PubMed ID: 25222579 [TBL] [Abstract][Full Text] [Related]
16. An association between parameters of liver blood flow and percentage hepatic replacement with tumour. Hunt TM; Flowerdew AD; Britten AJ; Fleming JS; Karran SJ; Taylor I Br J Cancer; 1989 Mar; 59(3):410-4. PubMed ID: 2930707 [TBL] [Abstract][Full Text] [Related]
18. A comparison of methods to measure the percentage hepatic replacement with colorectal metastases. Hunt TM; Flowerdew AD; Taylor I; Ackery DM; Blaquiere RM; Dewbury K Ann R Coll Surg Engl; 1989 Jan; 71(1):11-3. PubMed ID: 2647022 [TBL] [Abstract][Full Text] [Related]
19. Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study. Strasberg SM; Dehdashti F; Siegel BA; Drebin JA; Linehan D Ann Surg; 2001 Mar; 233(3):293-9. PubMed ID: 11224615 [TBL] [Abstract][Full Text] [Related]
20. Surgical treatment for extrahepatic recurrence after hepatectomy for colorectal metastases. Yoshidome H; Ito H; Kimura F; Ambiru S; Shimizu H; Togawa A; Ohtsuka M; Kato A; Nukui Y; Miyazaki M Hepatogastroenterology; 2004; 51(60):1805-9. PubMed ID: 15532831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]